Quick Hits Resources

Welcome to our Quick Hits Resources section, where we focus on the critical topic of treatment emergent adverse events (TEAEs) associated with androgen receptor inhibitors (ARIs) in prostate cancer treatment. Understanding the potential adverse events linked to each treatment is essential for optimising patient care and ensuring the best possible outcomes.

Prioritising the quality of life for patients is fundamental in treatment decision-making. TEAEs can lead to treatment discontinuation, increased healthcare costs, and a negative impact on patient well-being. Therefore, it is vital for healthcare professionals to be aware of these events to make informed choices that enhance patient care.

In this section, we are sharing three informative infographics that highlight key TEAEs associated with ARIs, specifically focusing on rash, fatigue, and cardiovascular issues.

These resources provide valuable insights into how these adverse events can affect patients and the importance of managing them effectively.

Explore the infographics below to gain a deeper understanding of the implications of TEAEs in prostate cancer treatment and discover strategies to improve patient quality of life.

For full information on adverse events for NUBEQA, please consult the Summary of Product Characteristics.